共 11 条
- [1] Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.[J].Vanessa S. Terra;Dominic C. Mills;Laura E. Yates;Sherif Abouelhadid;Jon Cuccui;Brendan W. Wren.Journal of Medical Microbiology.2012, Pt 7
- [2] Persistence of immune responses after a single dose of Novartis meningococcal serogroup A; C; W-135 and Y CRM-197 conjugate vaccine (Menveo?) or Menactra? among healthy adolescents.[J].Christopher J. Gill;Roger Baxter;Alessandra Anemona;Giuseppe Ciavarro;Peter Dull.Human Vaccines.2010, 11
- [3] Glycoconjugate vaccines and immune interference: A review [J]. VACCINE, 2010, 28 (34) : 5513 - 5523
- [6] The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses.[J].Alessia Melegaro;W. John Edmunds.European Journal of Epidemiology.2004, 4
- [8] O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions.[J].Inge Lerouge;Jos Vanderleyden.FEMS Microbiology Reviews.2001, 1